Profiel
Mats Lindskog currently works at OncoZenge AB, as Independent Director from 2025.
Mr. Lindskog also formerly worked at ACAP Invest AB, as Chief Executive Officer in 2012.
Mr. Lindskog received his graduate degree and doctorate degree from Royal Institute of Technology and undergraduate degree from Blekinge Tekniska Högskola.
Actieve functies van Mats Lindskog
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOZENGE AB | Directeur/Bestuurslid | 01-01-2025 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Corporate Officer/Principal | - |
Eerdere bekende functies van Mats Lindskog
| Bedrijven | Functie | Einde |
|---|---|---|
| WNTRESEARCH AB | Directeur/Bestuurslid | - |
| ACAP INVEST AB | Algemeen Directeur | - |
Opleiding van Mats Lindskog
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
ACAP Invest AB
ACAP Invest AB Investment Trusts/Mutual FundsMiscellaneous Provides investment services | Miscellaneous |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wntresearch AB
Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Blekinge Tekniska Högskola
Blekinge Tekniska Högskola Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
OncoZenge AB
OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
















